Hydrogen peroxide-generating nanomedicine for enhanced chemodynamic therapy

被引:66
作者
Yu, Peng [1 ]
Li, Xiaodong [3 ]
Cheng, Guohui [1 ]
Zhang, Xu [1 ]
Wu, Dan [2 ]
Chang, Jin [1 ]
Wang, Sheng [1 ]
机构
[1] Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China
[2] Zhejiang Univ Technol, Coll Chem & Biol Engn, Hangzhou 310014, Peoples R China
[3] Tianjin Med Univ, Hosp 2, Tianjin 300211, Peoples R China
基金
中国国家自然科学基金;
关键词
Nanomedicine; ROS; Chemodynamic therapy; Fenton reaction; Hydrogen peroxide; OXIDATIVE STRESS; CANCER-THERAPY; DOXORUBICIN; NANOPARTICLES; RESISTANCE; NANOREACTORS; STRATEGY; BACTERIA; GOLD;
D O I
10.1016/j.cclet.2021.02.015
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Chemodynamic therapy (CDT) is an emerging endogenous stimulation activated tumor treatment approach that exploiting iron-containing nanomedicine as catalyst to convert hydrogen peroxide (H2O2) into toxic hydroxyl radical ((OH)-O-center dot) through Fenton reaction. Due to the unique characteristics (weak acidity and the high H2O2 level) of the tumor microenvironment, CDT has advantages of high selectivity and low side effect. However, as an important substrate of Fenton reaction, the endogenous H2O2 in tumor is still insufficient, which may be an important factor limiting the efficacy of CDT. In order to optimize CDT, various H2O2-generating nanomedicines that can promote the production of H2O2 in tumor have been designed and developed for enhanced CDT. In this review, we summarize recently developed nanomedicines based on catalytic enzymes, nanozymes, drugs, metal peroxides and bacteria. Finally, the challenges and possible development directions for further enhancing CDT are prospected. (C) 2021 Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:2127 / 2138
页数:12
相关论文
共 71 条
[1]  
Bäckhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.05.012, 10.1016/j.chom.2015.04.004]
[2]   β-Lapachone Micellar Nanotherapeutics for Non-Small Cell Lung Cancer Therapy [J].
Blanco, Elvin ;
Bey, Erik A. ;
Khemtong, Chalermchai ;
Yang, Su-Geun ;
Setti-Guthi, Jagadeesh ;
Chen, Huabing ;
Kessinger, Chase W. ;
Carnevale, Kevin A. ;
Bornmann, William G. ;
Boothman, David A. ;
Gao, Jinming .
CANCER RESEARCH, 2010, 70 (10) :3896-3904
[3]   The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin [J].
Brozovic, Anamaria ;
Ambriovic-Ristov, Andreja ;
Osmak, Maja .
CRITICAL REVIEWS IN TOXICOLOGY, 2010, 40 (04) :347-359
[4]   A brief history of synthetic biology [J].
Cameron, D. Ewen ;
Bashor, Caleb J. ;
Collins, James J. .
NATURE REVIEWS MICROBIOLOGY, 2014, 12 (05) :381-390
[5]  
Coley W B, 1891, Ann Surg, V14, P199, DOI 10.1097/00000658-189112000-00015
[6]   The catalytic activity of "Naked" gold particles [J].
Comotti, M ;
Della Pina, C ;
Matarrese, R ;
Rossi, M .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2004, 43 (43) :5812-5815
[7]   Multifunctional Thermosensitive Liposomes Based on Natural Phase-Change Material: Near-Infrared Light-Triggered Drug Release and Multimodal Imaging-Guided Cancer Combination Therapy [J].
Dai, Yeneng ;
Su, Jinzhong ;
Wu, Kun ;
Ma, Wenkang ;
Wang, Bing ;
Li, Meixing ;
Sung, Pengfei ;
Shen, Qingming ;
Wang, Qi ;
Fan, Quli .
ACS APPLIED MATERIALS & INTERFACES, 2019, 11 (11) :10540-10553
[8]   Toxic Reactive Oxygen Species Enhanced Synergistic Combination Therapy by Self-Assembled Metal-Phenolic Network Nanoparticles [J].
Dai, Yunlu ;
Yang, Zhen ;
Cheng, Siyuan ;
Wang, Zhongliang ;
Zhang, Ruili ;
Zhu, Guizhi ;
Wang, Zhantong ;
Yung, Bryant C. ;
Tian, Rui ;
Jacobson, Orit ;
Xu, Can ;
Ni, Qianqian ;
Song, Jibin ;
Sun, Xiaolian ;
Niu, Gang ;
Chen, Xiaoyuan .
ADVANCED MATERIALS, 2018, 30 (08)
[9]   Pegylated Liposomal Doxorubicin A Review of its use in Metastatic Breast Cancer, Ovarian Cancer, Multiple Myeloma and AIDS-Related Kaposi's Sarcoma [J].
Duggan, Sean T. ;
Keating, Gillian M. .
DRUGS, 2011, 71 (18) :2531-2558
[10]  
Fan J.-X., 2019, ADV MATER, V31, DOI DOI 10.1002/adma.201808278